Welcome to KehindePopoola.com

DTN2021-42 – Brooklyn Immunotherapeutics, Inc. to Begin Listing and Trading on Nasdaq on Monday, October 25, 2021

Markets Impacted:

Products Impacted:

  • All Nasdaq and UTP Data Feeds

Contact Information:


What you need to know:

On Monday, October 25, 2021, Brooklyn Immunotherapeutics, Inc’s common stock (NYSE American: BTX) will be listed and begin trading on the Nasdaq Global Market. The common stock will be listed and traded under the current ticker symbol “BTX“.

Nasdaq requests that market data redistributors retain historical data for BTX prior to transfer date.

What are the issue details for the new Nasdaq listing?

The issue mapping for Brooklyn Immunotherapeutics, Inc. is as follows:

Issue Name NYSE American Ticker/CUSIP through Oct. 22, 2021 Nasdaq Ticker as of Oct. 25, 2021 Nasdaq Market Category Round Lot Size
Brooklyn Immunotherapeutics, Inc.
BTX / 114082100

BTX / 114082100
Nasdaq Global Market Common 100

What database changes do Nasdaq market data redistributors need to make to accommodate the new listing?

Nasdaq asks that all market data redistributors update their database to reflect the new listing market for Brooklyn Immunotherapeutics, Inc. after market close on Friday, October 22, 2021. Nasdaq requests that market data redistributors retain historical data for BTX.

When the issue moves from NYSE American to Nasdaq, firms will see a change in the consolidated data source for Brooklyn Immunotherapeutics, Inc. Please note that the consolidated market data for all Nasdaq-listed issues is disseminated via the UTP Quotation Data Feed (UQDF) and UTP Trade Data Feed (UTDF). Firms will begin to see quotation and trade data for Brooklyn Immunotherapeutics, Inc. on UQDF and UTDF beginning in the pre-market trading hours on Monday, October 25, 2021.

For firms that report end-usage numbers by the query, Nasdaq reminds them that the Level 1, Nasdaq Basic and Nasdaq Last Sale (NLS) counts should include quote and trade queries for Brooklyn Immunotherapeutics, Inc. (BTX) beginning on Monday, October 25, 2021.

Contact Information

If you have questions about Brooklyn Immunotherapeutics, Inc., please contact:

If you would like to register as a market maker in BTX please contact:

Email Alert Subscriptions:

Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq’s trading and data products, regulatory issues or marketplace initiatives.

Please follow Nasdaq on FacebookRSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

Have something to add? Share it in the comments.

Your email address will not be published. Required fields are marked *